Alzheimer's Association awards Longeveron $3 million grant for innovative clinical trial

(Alzheimer's Association) The Alzheimer's Association has awarded Longeveron LLC, a Miami-based biopharmaceutical company that develops cellular therapies for aging-related diseases, a $3 million grant to be applied to the company's mesenchymal stem cell Alzheimer's research.

Source: EurekAlert! - Medicine and Health - July 23, 2019 Category: International Medicine & Public Health Source Type: news